Literature DB >> 22441437

Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.

Stéphanie Roberge1, Pia Villa, Kypros Nicolaides, Yves Giguère, Merja Vainio, Abdelouahab Bakthi, Alaa Ebrashy, Emmanuel Bujold.   

Abstract

OBJECTIVE: To compare the effect of early administration of aspirin on the risk of preterm and term preeclampsia.
METHOD: A systematic review and meta-analysis of randomized controlled trials were performed. Women who were randomized to low-dose aspirin or placebo/no treatment at or before 16 weeks of gestation were included. The outcomes of interest were preterm preeclampsia (delivery <37 weeks) and term preeclampsia. Pooled relative risks (RR) with their 95% confidence intervals (CI) were computed.
RESULTS: The search identified 7,941 citations but only five trials on a combined total of 556 women fulfilled the inclusion criteria. When compared to controls, aspirin initiated ≤16 weeks of gestation was associated with a major reduction of the risk of preterm preeclampsia (RR 0.11, 95% CI 0.04-0.33) but had no significant effect on term preeclampsia (RR 0.98, 95% CI 0.42-2.33).
CONCLUSION: Low-dose aspirin administrated at or before 16 weeks of gestation reduces the risk of preterm but not term preeclampsia.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441437     DOI: 10.1159/000336662

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  70 in total

1.  Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin.

Authors:  Scott W Walsh; Daniel T Reep; S M Khorshed Alam; Sonya L Washington; Marwah Al Dulaimi; Stephanie M Lee; Edward H Springel; Jerome F Strauss; Daniel J Stephenson; Charles E Chalfant
Journal:  Reprod Sci       Date:  2020-06-17       Impact factor: 3.060

2.  Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers.

Authors:  Torri D Metz; Amanda A Allshouse; Anna G Euser; Kent D Heyborne
Journal:  Am J Obstet Gynecol       Date:  2014-04-23       Impact factor: 8.661

3.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

4.  Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China.

Authors:  J Liu; H Yang; Z Yin; X Jiang; H Zhong; D Qiu; F Zhu; R Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-17       Impact factor: 3.267

Review 5.  Preeclampsia: Association With Posterior Reversible Encephalopathy Syndrome and Stroke.

Authors:  Mollie McDermott; Eliza C Miller; Tatjana Rundek; Patricia D Hurn; Cheryl D Bushnell
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

Review 6.  Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  World J Nephrol       Date:  2014-11-06

7.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

8.  Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Juan Pedro Kusanovic; Eleazar Soto; Jennifer Lam; Zhong Dong; Nandor G Than; Lami Yeo; Edgar Hernandez-Andrade; Agustín Conde-Agudelo; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

9.  Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.

Authors:  Radwa Marawan AbdelHalim; Dalia Ibrahim Ramadan; Reham Zeyada; Ahmed Soliman Nasr; Iman Atef Mandour
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 10.  Aspirin vs Heparin for the Prevention of Preeclampsia.

Authors:  Vasiliki Katsi; Theoni Kanellopoulou; Thomas Makris; Petros Nihoyannopoulos; Efrosyni Nomikou; Dimitrios Tousoulis
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.